Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yu Wang, Weiwei Song, Qiang Xu, Yachao Liu, Hezhong Liu, Runzi Guo, Chuang-Jiun Chiou, Kun Gao, Baofeng Jin, Changfeng Chen, Zhongming Li, Jinqi Yan & Jiyun Yu. (2023) Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Yukinobu Kodama, Ayako Tokunaga, Junya Hashizume, Hiroo Nakagawa, Hitomi Harasawa, Tomoaki Kurosaki, Tadahiro Nakamura, Koyo Nishida, Mikiro Nakashima, Mitsuru Hashida, Shigeru Kawakami & Hitoshi Sasaki. (2021) Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice. Drug Delivery 28:1, pages 542-549.
Read now
Read now
Yuhang Tian, Zhao Liu, Haoyan Tan, Jiahui Hou, Xin Wen, Fan Yang & Wen Cheng. (2020) New Aspects of Ultrasound-Mediated Targeted Delivery and Therapy for Cancer. International Journal of Nanomedicine 15, pages 401-418.
Read now
Read now
Stephanie van de Wall, Karl Ljungberg, Peng Peng Ip, Annemarie Boerma, Maria L. Knudsen, Hans W. Nijman, Peter Liljeström & Toos Daemen. (2018) Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. OncoImmunology 7:10.
Read now
Read now
Marcelo Nazário Cordeiro, Rita de Cássia Pereira De Lima, Francesca Paolini, Alanne Rayssa da Silva Melo, Ana Paula Ferreira Campos, Aldo Venuti & Antonio Carlos De Freitas. (2018) Current research into novel therapeutic vaccines against cervical cancer. Expert Review of Anticancer Therapy 18:4, pages 365-376.
Read now
Read now
Sophie A. Aschenbroich. (2017) DNA vaccination resurfaces in the struggle against melioidosis. Virulence 8:8, pages 1483-1485.
Read now
Read now
Jinhong Chen, Lu Chen, Haochong Zhang & Yan Quan. (2017) Enhancing the antitumour-specific immunity of a lung DNA vaccine in vivo by fusion expression of MAGE-A3 and soluble PD-1. Biotechnology & Biotechnological Equipment 31:5, pages 1064-1069.
Read now
Read now
Lei Li & Nikolai Petrovsky. (2016) Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Review of Vaccines 15:3, pages 313-329.
Read now
Read now
Articles from other publishers (45)
Morgan E. Janes, Alexander P. Gottlieb, Kyung Soo Park, Zongmin Zhao & Samir Mitragotri. (2023) Cancer vaccines in the clinic. Bioengineering & Translational Medicine.
Crossref
Crossref
Aanshi Pandya, Yesha Shah, Nirjari Kothari, Humzah Postwala, Aayushi Shah, Priyajeet Parekh & Mehul R. Chorawala. (2023) The future of cancer immunotherapy: DNA vaccines leading the way. Medical Oncology 40:7.
Crossref
Crossref
Gabrielle P. Dailey, Erika J. Crosby & Zachary C. Hartman. (2022) Cancer vaccine strategies using self-replicating RNA viral platforms. Cancer Gene Therapy 30:6, pages 794-802.
Crossref
Crossref
Han‐Yup Yum, Sang A Han, Konstantin Konstantinov, Sang‐Woo Kim & Jung Ho Kim. (2023) Smart Triboelectric Nanogenerators Toward Human‐Oriented Technologies: Health Monitoring, Wound Healing, Drug Delivery. Advanced Materials Technologies 8:10.
Crossref
Crossref
Eivina Radzevičiūtė-Valčiukė, Jovita Gečaitė, Augustinas Želvys, Auksė Zinkevičienė, Rokas Žalnėravičius, Veronika Malyško-Ptašinskė, Aušra Nemeikaitė-Čenienė, Vytautas Kašėta, Natalija German, Jurij Novickij, Almira Ramanavičienė, Julita Kulbacka & Vitalij Novickij. (2023) Improving NonViral Gene Delivery Using MHz Bursts of Nanosecond Pulses and Gold Nanoparticles for Electric Field Amplification. Pharmaceutics 15:4, pages 1178.
Crossref
Crossref
Yanpeng Lv, Shuo Chen, Sixuan Wu, Xian Cheng, Jinjin Shi & Chenguo Yao. (2023) Study on B16 Cell Cytotoxicity by High Frequency Reversible Electroporation With Bleomycin That Induces Hallmarks of Immunogenic Death. IEEE Transactions on Biomedical Engineering 70:4, pages 1359-1367.
Crossref
Crossref
Helen Cho, Joe Binder, Risini Weeratna, Michael Dermyer, Stanley Dai, Antionio Boccia, Wei Li, Shangjin Li, Karin Jooss, James Merson & Robert E. Hollingsworth. (2022) Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens. Cancer Immunology, Immunotherapy 72:2, pages 287-300.
Crossref
Crossref
Alanne Rayssa da Silva Melo, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, Cristiane Moutinho Lagos de Melo, Anna Jéssica Duarte Silva, Marcus Vinicius de Aragão Batista & Antonio Carlos de Freitas. (2022) Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency. Genes 13:12, pages 2287.
Crossref
Crossref
Katarzyna Rakoczy, Monika Kisielewska, Mikołaj Sędzik, Laura Jonderko, Julia Celińska, Natalia Sauer, Wojciech Szlasa, Jolanta Saczko, Vitalij Novickij & Julita Kulbacka. (2022) Electroporation in Clinical Applications—The Potential of Gene Electrotransfer and Electrochemotherapy. Applied Sciences 12:21, pages 10821.
Crossref
Crossref
Ting Huang, Li Liu, Zheng Lv, Kelei Zhao, Qiong Yi & Jing Zhang. (2022) Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review. Vaccines 10:10, pages 1586.
Crossref
Crossref
Neftali Ortega Alarcon, Maddy Jaramillo, Heidi M. Mansour & Bo Sun. (2022) Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms. Pharmaceutics 14:7, pages 1448.
Crossref
Crossref
Jicong Cao, Eva Maria Novoa, Zhizhuo Zhang, William C. W. Chen, Dianbo Liu, Gigi C. G. Choi, Alan S. L. Wong, Claudia Wehrspaun, Manolis Kellis & Timothy K. Lu. (2021) High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies. Nature Communications 12:1.
Crossref
Crossref
Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Vanessa Acebes-Fernandez, Ángela-Patricia Hernández, Marina L. Garcia-Vaquero, Carlota Arias-Hidalgo, Halin Bareke, Enrique Montalvillo, Rafael Gongora & Manuel Fuentes. (2021) Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Tomohiro Enokida, Alvaro Moreira & Nina Bhardwaj. (2021) Vaccines for immunoprevention of cancer. Journal of Clinical Investigation 131:9.
Crossref
Crossref
Samantha J. Paston, Victoria A. Brentville, Peter Symonds & Lindy G. Durrant. (2021) Cancer Vaccines, Adjuvants, and Delivery Systems. Frontiers in Immunology 12.
Crossref
Crossref
Claudia A. Kornuta, Juan E. Bidart, Ivana Soria, Mariela Gammella, Valeria Quattrocchi, Juan S. Pappalardo, Stefano Salmaso, Vladimir P. Torchilin, Felipe Cheuquepán Valenzuela, Yanina P. Hecker, Dadin P. Moore, Patricia I. Zamorano & Cecilia A. Langellotti. (2020) MANα1‐2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV‐1. Transboundary and Emerging Diseases 68:2, pages 587-597.
Crossref
Crossref
Vitalij Novickij, Austėja Balevičiūtė, Paulius Ruzgys, Saulius Šatkauskas, Jurij Novickij, Auksė Zinkevičienė & Irutė Girkontaitė. (2020) Sub-microsecond electrotransfection using new modality of high frequency electroporation. Bioelectrochemistry 136, pages 107594.
Crossref
Crossref
Simone Hager, Frederic Julien Fittler, Ernst Wagner & Matthias Bros. (2020) Nucleic Acid-Based Approaches for Tumor Therapy. Cells 9:9, pages 2061.
Crossref
Crossref
Vanessa Acebes-Fernández, Alicia Landeira-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora & Manuel Fuentes. (2020) Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials 10:7, pages 1274.
Crossref
Crossref
Tamara Polajžer & Damijan Miklavčič. (2020) Development of adaptive resistance to electric pulsed field treatment in CHO cell line in vitro. Scientific Reports 10:1.
Crossref
Crossref
Alan Chen Chen, Renhuan Xu, Tao Wang, Junping Wei, Xiao-Yi Yang, Cong-Xiao Liu, Gangjun Lei, Herbert Kim Lyerly, Teri Heiland & Zachary Conrad Hartman. (2020) HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression. Journal for ImmunoTherapy of Cancer 8:1, pages e000258.
Crossref
Crossref
Ranveig Braathen, Heidi Cecilie Larsen Spång, Daniëla Maria Hinke, Jana Blazevski, Sonja Bobic, Even Fossum & Bjarne Bogen. (2020) A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza. Molecular Therapy - Methods & Clinical Development 17, pages 378-392.
Crossref
Crossref
Oscar Lucia, Hector Sarnago, Tomas Garcia-Sanchez, Lluis M. Mir & Jose M. Burdio. (2019) Industrial Electronics for Biomedicine: A New Cancer Treatment Using Electroporation. IEEE Industrial Electronics Magazine 13:4, pages 6-18.
Crossref
Crossref
Tchamie Kadja, Akash Kota & Vamsy P. Chodavarapu. (2019) Chip Scale Tunable Nanosecond Pulsed Electric Field Generator for Cell Electroporation. Chip Scale Tunable Nanosecond Pulsed Electric Field Generator for Cell Electroporation.
Jamile R. Silva, Natiely S. Sales, Mariângela O. Silva, Luana R. M. M. Aps, Ana C. R. Moreno, Elaine G. Rodrigues, Luís C. S. Ferreira & Mariana O. Diniz. (2019) Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model. Cancer Immunology, Immunotherapy 68:5, pages 753-763.
Crossref
Crossref
Sivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, Rajat Goyal, Nikhil Singla, Joyeeta Mukherjee, Shweta Chatrath, Philip Bergin, Jakub T. Kopycinski, Jill Gilmour, Sriram Kumar, Malathy Muthu, Sudha Subramaniam, Soumya Swaminathan, Srikanth Prasad Tripathy & Hanna Elizabeth Luke. (2019) Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India. PLOS ONE 14:3, pages e0213911.
Crossref
Crossref
Xiaobo Wang, Shaoyi Fan, Hehai Pan, Wenli Chen & Hua Wang. (2019) Cancer immunotherapy for metastasis: past, present and future. Briefings in Functional Genomics 18:2, pages 140-146.
Crossref
Crossref
Robert E. Hollingsworth & Kathrin Jansen. (2019) Turning the corner on therapeutic cancer vaccines. npj Vaccines 4:1.
Crossref
Crossref
Rodolfo Garza-Morales, Jose Perez-Trujillo, Elvis Martinez-Jaramillo, Odila Saucedo-Cardenas, Maria Loera-Arias, Aracely Garcia-Garcia, Humberto Rodriguez-Rocha, Esma Yolcu, Haval Shirwan, Jorge Gomez-Gutierrez & Roberto Montes-de-Oca-Luna. (2019) A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model. Cancers 11:1, pages 96.
Crossref
Crossref
Mohammed Mehadi Hassan Chowdhury, Khadizatul Kubra, Rupinder K. Kanwar & Jagat R. Kanwar. 2019. Biomedical Applications of Graphene and 2D Nanomaterials. Biomedical Applications of Graphene and 2D Nanomaterials
283
304
.
Saeed Farajzadeh Valilou & Mahsa Keshavarz-Fathi. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
129
143
.
Ren-You Pan, Wen-Hung Chung, Mu-Tzu Chu, Shu-Jen Chen, Hua-Chien Chen, Lei Zheng & Shuen-Iu Hung. (2018) Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. Journal of Immunology Research 2018, pages 1-9.
Crossref
Crossref
Rui Zhang, Margaret M. Billingsley & Michael J. Mitchell. (2018) Biomaterials for vaccine-based cancer immunotherapy. Journal of Controlled Release 292, pages 256-276.
Crossref
Crossref
Dominika Hobernik & Matthias Bros. (2018) DNA Vaccines—How Far From Clinical Use?. International Journal of Molecular Sciences 19:11, pages 3605.
Crossref
Crossref
Manuela Chiper, Karen Niederreither & Guy Zuber. (2017) Transduction Methods for Cytosolic Delivery of Proteins and Bioconjugates into Living Cells. Advanced Healthcare Materials 7:6.
Crossref
Crossref
Ayumu Yano, Keita Takahashi, Yusuke Mori, Shiori Watanabe, Yuki Hanamura, Tsuyoshi Sugiyama & Naoki Inoue. (2018) Peyer’s Patches as a Portal for DNA Delivery by <i>Lactococcus lactis</i> <i>in Vivo</i>. Biological and Pharmaceutical Bulletin 41:2, pages 190-197.
Crossref
Crossref
Shumin Huang & Xinxin Yu. (2018) Antitumor immunity of DNA vaccine based on CTLA-4 fused with HER2 against colon carcinoma. European Journal of Inflammation 16, pages 205873921876814.
Crossref
Crossref
Chahal Kailashiya, Hanjabam Barun Sharma & Jyotsna Kailashiya. (2017) Telomerase based anticancer immunotherapy and vaccines approaches. Vaccine 35:43, pages 5768-5775.
Crossref
Crossref
Sayyed Nilofar DanishmalikJeong-Im Sin. (2017) Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model. DNA and Cell Biology 36:9, pages 801-811.
Crossref
Crossref
Youguang Zhao, Zhitao Wei, Hang Yang, Xiaowei Li, Qiwu Wang, Liang Wang & Shadan Li. (2017) Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4). Biomedicine & Pharmacotherapy 90, pages 147-152.
Crossref
Crossref
Sayyed Nilofar Danishmalik, Si-Hyeong Lee & Jeong-Im Sin. (2017) Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control. Oncotarget 8:16, pages 26771-26788.
Crossref
Crossref
Zhen Yang, DanDan Jiang, Qiang Zhu, BinBin Xiao & Liang An Chen. (2016) The immunogenicity and anti-tumor effects of a lung cancer DNA vaccine harboring a MUC-1 and GM-CSF fusion gene. Brazilian Archives of Biology and Technology 59:0.
Crossref
Crossref
T.J. Mai, R. Ma, Z. Li & S.C. Bi. (2016) Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer. Brazilian Journal of Medical and Biological Research 49:11.
Crossref
Crossref
Pier-Luigi Lollini, Federica Cavallo, Patrizia Nanni & Elena Quaglino. (2015) The Promise of Preventive Cancer Vaccines. Vaccines 3:2, pages 467-489.
Crossref
Crossref
Alessia Lamolinara, Lorenzo Stramucci, Albana Hysi, Manuela Iezzi, Cristina Marchini, Marianna Mariotti, Augusto Amici & Claudia Curcio. (2015) Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor. Journal of Immunology Research 2015, pages 1-10.
Crossref
Crossref